CETUXIMAB (ERBITUX) INJECTION – TREATMENT FOR MULTIPLE CANCER
Cancers of the colon, rectum, and head and neck are all treated with Erbitux infusion. It aids in identifying the cancer cells for the immune system of the body to destroy.
Under the direction of a physician, Erbitux Infusion is administered as an injection. Your doctor will determine the appropriate dosage and frequency of administration for you. This is based on the condition you are being treated for and is subject to change.
USES OF CETUXIMAB (ERBITUX) INJECTION
- Head and neck cancer
- Cancer of the colon and rectum
WORKS OF CETUXIMAB (ERBITUX) INJECTION
A monoclonal antibody called Erbitux Infusion selectively interacts with receptors on cancer cells. As a result, it marks the cancerous cells for elimination by the immune system.
SIDE EFFECTS OF CETUXIMAB (ERBITUX) INJECTION
- Skin rash
- Infusion reaction
- Decreased magnesium level in blood
- Increased liver enzymes
WARNING & PRECAUTIONS
The negative effects of Erbitux injection may impair your ability to operate a motor vehicle.
Patients with kidney problems can probably utilize Erbitux infusions without risk. Since there isn’t much information available, it’s possible that these people won’t require an Erbitux Infusion dose change. Please speak with your physician.
On the usage of Erbitux Infusion in patients with liver illness, there is not much information available. Please speak with your physician.
Fedelty Health Care is a Cetuximab third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.